Rapid Innovation is Reshaping Oncology: Stocks in Focus

An updated edition of the December 17, 2025, article.The global oncology market is entering a phase of accelerated transformation, driven by rising cancer incidence, demographic shifts and rapid scientific progress. The American Cancer Society estimates that the United States will see about 2.1 million new cancer diagnoses and more than 626,000 cancer-related deaths in 2026. Globally, lifestyle-related risk factors and demographic shifts continue to increase cancer prevalence, supporting sustained growth in ...